Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| AMC-01 | C27H27BrN2O6 | 1047978-71-1 | Details |
| GPX4-IN-6 | C18H17BrFNO5 | 2922824-07-3 | Details |
| 9(S)-HOTrE | C18H30O3 | 89886-42-0 | Details |
| Saccharocarcin A | C67H101NO20 | 158475-32-2 | Details |
| MCTR3 | C25H37NO5S | 1784701-63-8 | Details |
| Docosane | C22H46 | 629-97-0 | Details |
| GSK046 | C23H27FN2O4 | 2474876-09-8 | Details |
| Eclitasertib | C19H18N6O3 | 2125450-76-0 | Details |
| NF-κΒ activator 1 | C16H11FN2O2S | 2387524-59-4 | Details |
| Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
| Elsinochrome A | C30H24O10 | 24568-67-0 | Details |
| PCSK9 Protein, Human, Recombinant (D374Y & V474I & G670E, His) | Details |
| SI 60 | C18H17F6OSSb | 133152-67-7 | Details |
| Vanillic acid glucoside | C14H18O9 | 32142-31-7 | Details |
| Trastuzumab deruxtecan | 1826843-81-5 | Details |
| Kansuinine A | C37H46O15 | 57701-86-7 | Details |
| 10'-Desmethoxystreptonigrin | C24H20N4O7 | 136803-89-9 | Details |
| (R)-Naroparcil | 252647-51-1 | Details |
| 25-Desacetyl Rifampicin | C41H56N4O11 | 16783-99-6 | Details |
| CA77.1 | C16H12ClN3O | 2412270-22-3 | Details |
| Shepherdin 79-87 acetate | Details |
| Arofylline | C14H13ClN4O2 | 136145-07-8 | Details |
| 11β-HSD1-IN-12 | C19H27ClN2O3S | 872506-67-7 | Details |
| Gantofiban | C21H29N5O6 | 183547-57-1 | Details |
| 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | C19H37Na2O7P | 17618-08-5 | Details |
| CIA-1 (Free base) | C17H19N3O2S | 452087-38-6 | Details |
| C2-8 | C19H14Br2N2O3S | 300670-16-0 | Details |
| Olanzapine impurity L HCl | C12H12ClN3S | 138564-60-0 | Details |
| CAY10770 | C14H20N4O2 | 2428734-45-4 | Details |
| PKI 14-22 amide, myristoylated Acetate | Details |
| PF-07258669 | C25H27FN6O2 | 2755890-53-8 | Details |
| (±)5(6)-EpETE methyl ester | C21H32O3 | 127716-49-8 | Details |
| 17-hydroxy Venturicidin A | C41H67NO12 | 113204-43-6 | Details |
| 5-Aminothalidomide | C13H11N3O4 | 191732-76-0 | Details |
| FGF22-IN-1 | C14H11N3OS | 113143-13-8 | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| DiR iodide | C63H101IN2 | Details |
| AT-121 | C24H38N4O3S | 2099681-31-7 | Details |
| 2,3-dihydro-1H-indene-5-sulfonamide | C9H11NO2S | 35203-93-1 | Details |
| PD-1/PD-L1-IN-9 | C22H24N2O2 | 2628506-54-5 | Details |
| Ciamexon | C11H13N3O | 75985-31-8 | Details |
| Uridine-5'-monophosphate (sodium salt hydrate) | C9H13N2Na2O10P | 681435-27-8 | Details |
| EM-12 | C13H12N2O3 | 26581-81-7 | Details |
| Rel-TREM2 agonist-2 | C24H23ClFN5O | 2738485-99-7 | Details |
| PACMA 31 | C21H22N2O6S | 1401089-31-3 | Details |
| 4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo- | C25H22N4O5S | 939760-13-1 | Details |
| Protonstatin-1 | C8H5NO2S2 | 521972-99-6 | Details |
| ATG7-IN-1 | C17H19FN6O5S2 | 2226229-87-2 | Details |
| Venadaparib | C23H23FN4O2 | 1681017-83-3 | Details |
| ANT3310 | C6H10FN2NaO5S | 2410688-61-6 | Details |
| DPTN dihydrochloride | C22H18N4OS.2ClH | 325767-87-1 | Details |
| GGACK (hydrochloride) | Details |
| Scandoside | C16H22O11 | 18842-99-4 | Details |
| Nexinhib20 | C15H16N4O3 | 331949-35-0 | Details |
| Secoisolariciresinol diglucoside | C32H46O16 | 158932-33-3 | Details |
| 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | C25H33F3O5 | 195503-20-9 | Details |
| PRX-07034 hydrochloride | 903580-39-2 | Details |
| Aurora kinase inhibitor-2 | C23H20N4O3 | 331770-21-9 | Details |
| 1,2,3-Trilinoelaidoyl-rac-glycerol | C57H98O6 | 5188-25-0 | Details |
| Methyl 3,4-Dihydroxyphenylacetate | C9H10O4 | 25379-88-8 | Details |
| 13(S)-HpOTrE(γ) | C18H30O4 | 121107-97-9 | Details |
| (R)-Monepantel | C20H13F6N3O2S | 887148-70-1 | Details |
| sbp-7455 | C16H17F3N4O2 | 1884222-74-5 | Details |
| IMB-XMA0038 | C11H10N4O6 | 921812-26-2 | Details |
| Solpecainol | C18H23NO3 | 155321-96-3 | Details |
| Arecoline | C8H13NO2 | 63-75-2 | Details |
| SphK1&2-IN-1 | C14H14N2O3S | 1415662-57-5 | Details |
| 11β-HSD1 inibitor 19 | C19H16ClF4N3O2S | 946400-19-7 | Details |
| GV-150013X | C33H34N4O3 | 151386-96-8 | Details |
| Kukoamine B mesylate | C28H42N4O6.CH4O3S | 1375179-86-4 | Details |
| 3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid | C15H11Cl2NO2 | 300816-42-6 | Details |
| PD 198306 | C18H16F3IN2O2 | 212631-61-3 | Details |
| Pinolenic Acid ethyl ester | C20H34O2 | 493015-74-0 | Details |
| BMS-488043 | C22H22N4O5 | 452296-83-2 | Details |
| Dihydrosinapyl alcohol | C11H16O4 | 20736-25-8 | Details |
| CYM2503 | C45H55N5O7 | 1308833-36-4 | Details |
| Rhod-2 (sodium salt) | C40H39N4Na3O11 | Details |
| GSK-3β inhibitor 10 | C12H12N2O3S | 1198098-03-1 | Details |
| 1,3-BUTANEDIOL | C4H10O2 | 107-88-0 | Details |
| VT104 | C25H19F3N2O | 2417718-25-1 | Details |
| LMPTP INHIBITOR 1 hydrochloride | C28H37ClN4O | 2310135-38-5 | Details |
| Pomisartan 2HCl | Details |
| 1,3,6,8-Tetrahydroxynaphthalene | C10H8O4 | 18512-30-6 | Details |
| CYP2A6-IN-1 | C12H16F3N | 912291-11-3 | Details |
| ABC34 | C31H33N5O6 | 1831135-56-8 | Details |
| Dihydro Montelukast | C35H38ClNO3S | 142147-67-9 | Details |
| Calcifediol monohydrate | C27H46O3 | 63283-36-3 | Details |
| Vantictumab | 1345009-45-1 | Details |
| Ibritumomab | Details |
| Tazomeline | C14H23N3S2 | 131987-54-7 | Details |
| α-Conotoxin GI acetate | Details |
| MBP MAPK Substrate acetate | Details |
| NT-0796 | C23H27N3O4 | 2272917-13-0 | Details |
| 6'-hydroxydihydrocinchonidine | C19H24N2O2 | 5962-19-6 | Details |
| Qa-1b&B2M&Qdm (AMAPRTLLL) Monomer Protein, Mouse, MHC (His & Avi) | Details |
| 4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid | C11H7NO4S | 199167-79-8 | Details |
| Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | C42H32O21 | 205370-59-8 | Details |
| 1,4-DPCA | C13H8N2O3 | 331830-20-7 | Details |
| 4-Nitrophenyl dodecanoate | C18H27NO4 | 1956-11-2 | Details |
| AVG-233 | C26H22ClN5O3 | 2151937-80-1 | Details |
| Product Total： Product Page： | ||||
| 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 | ||||